PACS CEO sells 150K shares under trading plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PACS Group, Inc. (PACS) director and Co-Founder, CEO & Chairman Murray Jason Hulse reported open-market sales of an aggregate 150,550 shares of common stock on August 20–21, 2026, in multiple transactions at weighted average prices in the low-to-mid $40s per share, effected under a Rule 10b5-1 trading plan adopted on May 18, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F4 | 31,654 | $43.6063 | $1.38M |
| Sale | Common Stock F1, F5 | 27,590 | $44.2469 | $1.22M |
| Sale | Common Stock F1, F2 | 77,427 | $43.7714 | $3.39M |
| Sale | Common Stock F1, F3 | 13,879 | $44.7625 | $621K |
Footnotes (5)
- F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
- F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
open market or private transaction financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did PACS (PACS Group, Inc.) disclose in this Form 4?
Were the August 2026 PACS (PACS) stock sales made under a Rule 10b5-1 plan?
What were the price ranges for the PACS (PACS) insider sales reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.